RTP Chapter: Supply on the Move - A Panel on Direct to Patient & Decentralized Delivery
This is a hybrid event
Location:
NC Biotech Center
15 TW Alexander Dr
Durham, NC 27713
Virtual Dial-in link:
Event Description:
Direct-to-Patient (DtP) shipment of Investigational Product (IP) is a key tool in implementing decentralized trials. In this session a panel of speakers from Catalent, Science 37 and pharma will discuss operational challenges, considerations and opportunities with DtP.
Speakers:
Dr. Debra Weinstein,
Chief Medical Officer, Science 37
Michelle Giovannucci
Director, Pharmacist in Charge at Catalent (DtP pharmacy operations)
Amber Brown
Global Depots & Distribution at Catalent (clinical logistics/returns)-
Learning Objectives:
- Why a pharmacy matters in DtP
- Operational challenges at clinical sites
- Global distribution considerations
- Study design triggers for DtP
Event Agenda:
6:00 - 6:30 | Appetizers and Open Networking
6:30 - 7:30 | Presentation
7:30 - 8:00 | Open Networking
Registration Information:
After registering, please visit the event's community page to find the login information or any additional event updates, and to communicate with the event organizer.
The educational portion of this event may be self-reported as 1 point toward an attendee’s Maintenance of Certification. These points are subject to review and acceptance by the Academy of Clinical Research Professionals in accordance with the criteria established. Attendees should keep a record of event participation in case they are randomly selected to participate in the maintenance verification process. The Chapter can provide a certificate of attendance upon request.
#DCT
#StudyConduct
#TrialManagement
#StudyandSiteManagement